MENU
FGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

FibroGen (FGEN) Earnings Date & Reports

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

FGEN is expected to report earnings to fall 155.56% to -10 cents per share on May 12

FibroGen FGEN Stock Earnings Reports
Q1'25
Est.
$-0.10
Q4'24
Beat
by $0.35
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.16
Q1'24
Beat
by $0.08
The last earnings report on March 17 showed earnings per share of 18 cents, beating the estimate of -17 cents. With 613.37K shares outstanding, the current market capitalization sits at 30.90M.
View a ticker or compare two or three
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biotechnology-based drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
409 Illinois Street
Phone
+1 415 978-1200
Employees
486
Web
https://www.fibrogen.com